China leaps ahead of U.S. with plans for track-and-trace system

China's drug industry and regulatory oversight are often painted as backward compared with more established pharma markets. But Chinese regulators have set out new rules and a three-year plan that could move it ahead of the U.S. when it comes to monitoring drugs through the supply chain. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.